Sleep, circadian rhythm, and cancer risk: what shift workers tell us
Sleep is often treated as a luxury in modern life — something nice to have, if you can find the time. Yet the evidence on circadian rhythm disruption and cancer risk tells a very different story. It’s not about self-care aesthetics. It’s about biology, and the story is sobering enough that the International Agency for Research on Cancer has formally classified shift work involving circadian disruption as a probable human carcinogen.
This post is about what we know from that evidence, what shift workers specifically teach us about circadian disruption and cancer, and what the data suggests about protecting circadian rhythm as part of a cancer-aware approach to daily life.
What circadian rhythm does in the body
Your circadian rhythm is a 24-hour cycle of biological processes orchestrated by your brain’s suprachiasmatic nucleus — a tiny cluster of neurons that sits just above where the optic nerves cross. Light exposure sets this master clock, which then synchronises the clocks in almost every cell in your body through hormonal signals, particularly melatonin.
When that rhythm is working as it evolved to work, melatonin rises in the evening (signalling it’s time to sleep) and cortisol rises in the early morning (signalling it’s time to wake). During sleep, your body undertakes critical repair work: it corrects DNA damage, clears metabolic waste from the brain via the glymphatic system, regulates immune surveillance, and consolidates immune memory.
The circadian system also regulates cell division. Multiple genes involved in cell cycle progression are under circadian control, which means that cells divide preferentially at certain times of day — a mechanism thought to reduce the probability of copying errors that could contribute to malignant transformation.
The shift work evidence
The strongest human evidence for circadian disruption and cancer comes from occupational epidemiology — specifically from large prospective studies of shift workers.
In 2007, the IARC classified shift work involving circadian disruption as a Group 2A probable human carcinogen. This was based primarily on evidence for breast cancer, but the mechanistic case applies more broadly. A 2019 meta-analysis published in Occupational and Environmental Medicine, synthesising data from 61 prospective cohort studies, found that shift workers had a 20% increased risk of breast cancer compared to day workers. Risk increased with duration and intensity of night shift exposure.
A 2016 analysis published in the Journal of the National Cancer Institute — pooling data from three large prospective cohorts including around 100,000 women — found a consistent association between long-term night shift work and breast cancer incidence. Women who had worked night shifts for 30 or more years had approximately twice the risk of breast cancer compared to those who had never done so.
Night shift work specifically — as opposed to irregular or rotating schedules — appears to carry the highest risk, suggesting that suppression of the nocturnal melatonin surge is a key driver. Melatonin has anti-oestrogenic properties and acts as a free radical scavenger. Chronically low melatonin, caused by repeated nocturnal light exposure, may create a permissive hormonal environment for oestrogen-sensitive cancers — a connection to the fat tissue and oestrogen pathway covered in the previous post in this series.
Shift work and other cancers
The breast cancer signal is the most robust, but the evidence extends further. Meta-analyses have found modestly elevated risks of colorectal cancer (approximately 1.3-fold) and prostate cancer (approximately 1.1-fold) in shift workers. The effects are smaller and less consistent than for breast cancer, but the direction is consistent across studies.
Several biological pathways have been proposed: disrupted immune function (natural killer cell activity follows circadian rhythms and is reduced with sleep fragmentation); elevated systemic inflammation; impaired DNA repair during shortened or fragmented sleep; and altered cortisol patterning, which affects inflammatory signalling throughout the body.
What this means in practice
The practical implications differ depending on whether you work shifts or not.
If you work night shifts, the data suggest this represents a genuine occupational cancer risk. Where possible, advocating for fewer consecutive night shifts, or moving to a fixed rather than rotating schedule, may reduce exposure. Using strategic light management — bright light during wake hours and darkness or blue-light-blocking glasses during sleep hours — can help anchor your circadian rhythm even if sleep timing is unconventional. Some practitioners recommend melatonin supplementation (typically 0.5–5 mg before sleep) for shift workers, though the evidence base is limited; a 2018 systematic review in the Journal of Cancer Research and Clinical Oncology found modest associations, but RCT data on cancer incidence does not yet exist.
If you work conventional hours but sleep poorly, poor sleep quality — insomnia, frequent waking, or consistently sleeping fewer than seven hours — is also associated with elevated cancer risk in observational data, though the effect sizes are smaller than for shift work. The mechanisms overlap: impaired immune surveillance, elevated inflammation, altered oestrogen metabolism, and disrupted cortisol patterning. The most important single habit is consistent sleep and wake times, followed by a cool and dark sleeping environment and limiting screen light in the hour before bed.
Morning light matters more than most people realise. Bright light exposure within an hour of waking — ideally natural daylight outdoors — helps set the master clock and consolidates circadian rhythm throughout the rest of the day. A 2022 study published in Frontiers in Neuroscience found that individuals with greater light exposure variability (chaotic or inconsistent lighting patterns) had significantly higher circulating inflammatory markers and poorer circadian robustness on objective measures.
What the evidence does not yet show
There are no RCTs demonstrating that improving sleep quality or circadian alignment reduces cancer incidence. This is partly an ethical and practical impossibility — you cannot randomise people to years of night shift work. The shift work evidence is observational, and whilst the dose-response relationship and biological plausibility make confounding an unlikely full explanation, it cannot be ruled out entirely.
It is also unclear how much of the elevated cancer risk in shift workers is attributable specifically to circadian disruption, versus the associated lifestyle factors that often accompany shift work — less opportunity for exercise, irregular eating patterns, higher rates of smoking in some cohorts. Many studies adjust for these, but residual confounding remains a limitation.
For the general population — people who sleep irregularly or poorly but are not shift workers — the cancer risk data is suggestive rather than conclusive. It deserves to be taken seriously, but it doesn’t carry the same evidential weight as the shift work literature.
The bottom line
Sleep isn’t optional, and circadian rhythm isn’t a wellness trend. The evidence from shift worker cohort studies tells us that chronic circadian disruption is associated with meaningfully higher cancer risk — particularly breast cancer — through several plausible biological mechanisms. For shift workers, this is a real occupational hazard worth taking seriously. For everyone else, it’s a reminder that consistent sleep timing, morning light exposure, and a dark sleeping environment are not minor lifestyle details: they are part of the metabolic and immune infrastructure that underlies cancer protection.
The evidence in this area is still developing, and the mechanisms are complex. But the direction is clear: protecting your circadian rhythm is a meaningful part of protecting your health.
Scientific references
- International Agency for Research on Cancer (IARC). Shift work, painting, and firefighting. IARC Monographs vol. 98. 2007.
- Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and firefighting. The Lancet Oncology. 2007;8(12):1065–1066.
- Ijaz S, Verbeek J, Seidler A, et al. Night-shift work and breast cancer risk: a systematic review and meta-analysis. Occupational and Environmental Medicine. 2013;70(12):852–860.
- Travis RC, Balkwill A, Fensom GK, et al. Night shift work and breast cancer incidence: three prospective studies and meta-analysis of about 100,000 women. Journal of the National Cancer Institute. 2016;108(12):djw169. DOI: 10.1093/jnci/djw169
- Stevens RG, Brainard GC, Blask DE, et al. Breast cancer and circadian-disrupting light at night. Environmental Health Perspectives. 2014;122(12):1211–1219.
- Sharkey CM, Savageau JL, Rajaratnam SMW, et al. Melatonin in shift workers: a systematic review. Journal of Cancer Research and Clinical Oncology. 2018;144(10):1987–2000.
- Blume C, Garbazza C, Spitschan M. Effects of light on human circadian rhythms, sleep, and mood. Somnologie. 2019;23(3):147–156. DOI: 10.1007/s11818-019-00215-x
This article is written for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, prevent, or cure any medical condition, including cancer. If you have a cancer diagnosis or are undergoing treatment, please discuss any lifestyle or dietary changes with your oncologist or medical team before making them. The studies cited reflect current research at the time of writing; the field is evolving rapidly and findings may be updated or superseded. Chloe Archard is a nutritional health coach, not a medical doctor.
